Home
>
National Drug Code (NDC)
>
Fenoglide
Fenoglide - 52725-495-07 - (fenofibrate)
Drug Information of Fenoglide
| Product NDC: | 52725-495 |
| Proprietary Name: | Fenoglide |
| Non Proprietary Name: | fenofibrate |
| Active Ingredient(s): | 120 mg/1 & nbsp; fenofibrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Fenoglide
| Product NDC: | 52725-495 |
| Labeler Name: | Shore Therapeutics, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022118 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101118 |
Package Information of Fenoglide
| Package NDC: | 52725-495-07 |
| Package Description: | 6 BOTTLE, PLASTIC in 1 BOX (52725-495-07) > 7 TABLET in 1 BOTTLE, PLASTIC |
NDC Information of Fenoglide
| NDC Code | 52725-495-07 |
| Proprietary Name | Fenoglide |
| Package Description | 6 BOTTLE, PLASTIC in 1 BOX (52725-495-07) > 7 TABLET in 1 BOTTLE, PLASTIC |
| Product NDC | 52725-495 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fenofibrate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20101118 |
| Marketing Category Name | NDA |
| Labeler Name | Shore Therapeutics, Inc |
| Substance Name | FENOFIBRATE |
| Strength Number | 120 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [Chemical/Ingredient] |
